{"id":"https://openalex.org/W2890978005","doi":"https://doi.org/10.1080/19420862.2018.1517565","title":"Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia","display_name":"Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia","publication_year":2018,"publication_date":"2018-09-05","ids":{"openalex":"https://openalex.org/W2890978005","doi":"https://doi.org/10.1080/19420862.2018.1517565","mag":"2890978005","pmid":"https://pubmed.ncbi.nlm.nih.gov/30183491","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6284592"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2018.1517565","doi":"https://doi.org/10.1080/19420862.2018.1517565","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1517565","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1080/19420862.2018.1517565","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055608551","display_name":"Douglas D. Leipold","orcid":"https://orcid.org/0000-0003-2116-4277","observed_orcids":["https://orcid.org/0000-0003-2116-4277"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Douglas D. Leipold","raw_affiliation_strings":["Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-2116-4277","affiliations":[{"raw_affiliation_string":"Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017526947","display_name":"Isabel Figueroa","orcid":"https://orcid.org/0000-0001-9204-9132","observed_orcids":["https://orcid.org/0000-0001-9204-9132"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isabel Figueroa","raw_affiliation_strings":["Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056113477","display_name":"Shabkhaiz Masih","orcid":"https://orcid.org/0000-0003-2614-9375","observed_orcids":["https://orcid.org/0000-0003-2614-9375"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shabkhaiz Masih","raw_affiliation_strings":["Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-2614-9375","affiliations":[{"raw_affiliation_string":"Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014057621","display_name":"Brandon Latifi","orcid":"https://orcid.org/0000-0002-8309-8490","observed_orcids":["https://orcid.org/0000-0002-8309-8490"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Latifi","raw_affiliation_strings":["Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-8309-8490","affiliations":[{"raw_affiliation_string":"Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070060056","display_name":"Victor Yip","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor Yip","raw_affiliation_strings":["Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075622397","display_name":"Ben\u2010Quan Shen","orcid":"https://orcid.org/0000-0002-8214-6825","observed_orcids":["https://orcid.org/0000-0002-8214-6825"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ben-Quan Shen","raw_affiliation_strings":["Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086858204","display_name":"Randall C. Dere","orcid":"https://orcid.org/0000-0003-4120-7828","observed_orcids":["https://orcid.org/0000-0003-4120-7828"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randall C. Dere","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-4120-7828","affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003116288","display_name":"Montserrat Carrasco\u2010Triguero","orcid":"https://orcid.org/0000-0002-2805-1008","observed_orcids":["https://orcid.org/0000-0002-2805-1008"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Montserrat Carrasco-Triguero","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083832803","display_name":"M. Violet Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Violet Lee","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005988952","display_name":"Ola M. Saad","orcid":"https://orcid.org/0000-0002-2607-8901","observed_orcids":["https://orcid.org/0000-0002-2607-8901"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ola M. Saad","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011162474","display_name":"Luna Liu","orcid":"https://orcid.org/0000-0001-9748-546X","observed_orcids":["https://orcid.org/0000-0001-9748-546X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luna Liu","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041343485","display_name":"Jintang He","orcid":"https://orcid.org/0000-0001-9118-1086","observed_orcids":["https://orcid.org/0000-0001-9118-1086"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jintang He","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-9118-1086","affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005669715","display_name":"Dian Su","orcid":"https://orcid.org/0000-0003-4572-462X","observed_orcids":["https://orcid.org/0000-0003-4572-462X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dian Su","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-4572-462X","affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026735760","display_name":"Keyang Xu","orcid":"https://orcid.org/0000-0002-7049-2528","observed_orcids":["https://orcid.org/0000-0002-7049-2528"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keyang Xu","raw_affiliation_strings":["Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005739369","display_name":"Brian R. Vuillemenot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian R. Vuillemenot","raw_affiliation_strings":["Safety Assessment Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062578335","display_name":"Steven T. Laing","orcid":"https://orcid.org/0000-0002-6079-3095","observed_orcids":["https://orcid.org/0000-0002-6079-3095"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven T. Laing","raw_affiliation_strings":["Safety Assessment Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103156273","display_name":"Melissa M. Schutten","orcid":"https://orcid.org/0009-0001-6209-9400","observed_orcids":["https://orcid.org/0009-0001-6209-9400","https://orcid.org/0000-0002-6808-3899"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Schutten","raw_affiliation_strings":["Safety Assessment Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055879067","display_name":"Katherine R. Kozak","orcid":"https://orcid.org/0000-0003-3751-7225","observed_orcids":["https://orcid.org/0000-0003-3751-7225"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine R. Kozak","raw_affiliation_strings":["Biochemical and Cellular Pharmacology Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-3751-7225","affiliations":[{"raw_affiliation_string":"Biochemical and Cellular Pharmacology Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025817932","display_name":"Bing Zheng","orcid":"https://orcid.org/0000-0003-3443-7297","observed_orcids":["https://orcid.org/0000-0003-3443-7297"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bing Zheng","raw_affiliation_strings":["Translational Oncology Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Oncology Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022150086","display_name":"Andrew G. Polson","orcid":"https://orcid.org/0000-0003-3289-6502","observed_orcids":["https://orcid.org/0000-0003-3289-6502"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew G. Polson","raw_affiliation_strings":["Translational Oncology Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-3289-6502","affiliations":[{"raw_affiliation_string":"Translational Oncology Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087570789","display_name":"Amrita V. Kamath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amrita V. Kamath","raw_affiliation_strings":["Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Translational Pharmacokinetics Department, Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055608551"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":0.9334,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.6960596,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"10","issue":"8","first_page":"1312","last_page":"1321"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.41670000553131104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.41670000553131104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.413100004196167,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.03240000084042549,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8799999952316284},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cll-1","display_name":"CLL-1","score":0.8980000019073486},{"id":"https://openalex.org/keywords/pyrrolobenzodiazepine-dimer","display_name":"pyrrolobenzodiazepine dimer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9639999866485596},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":1.0},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.6629999876022339},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.7519999742507935},{"id":"https://openalex.org/keywords/antibody-stability","display_name":"antibody stability","score":0.5379999876022339},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.7919999957084656},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.6039999723434448},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":1.0}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6846685409545898},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6663494110107422},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6302434206008911},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6237083673477173},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6223427653312683},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5713502168655396},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5571914911270142},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.5429645776748657},{"id":"https://openalex.org/C2778623314","wikidata":"https://www.wikidata.org/wiki/Q412685","display_name":"Gemtuzumab ozogamicin","level":5,"score":0.540503740310669},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5206429362297058},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5098292231559753},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5032183527946472},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.470418244600296},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.44486740231513977},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27251794934272766},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20724135637283325},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2001805603504181},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.13696351647377014},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011975","descriptor_name":"Receptors, Mitogen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D037181","descriptor_name":"Lectins, C-Type","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/19420862.2018.1517565","doi":"https://doi.org/10.1080/19420862.2018.1517565","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1517565","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6284592","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6284592/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6284592/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:5256772","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6284592","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30183491","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30183491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/19420862.2018.1517565","doi":"https://doi.org/10.1080/19420862.2018.1517565","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1517565","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2890978005.pdf","grobid_xml":"https://content.openalex.org/works/W2890978005.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1555185942","https://openalex.org/W1968856619","https://openalex.org/W1999212901","https://openalex.org/W2008716770","https://openalex.org/W2024763401","https://openalex.org/W2030249962","https://openalex.org/W2043028214","https://openalex.org/W2057680307","https://openalex.org/W2064424529","https://openalex.org/W2109065151","https://openalex.org/W2113753666","https://openalex.org/W2116150122","https://openalex.org/W2121360288","https://openalex.org/W2123460144","https://openalex.org/W2179176827","https://openalex.org/W2179836657","https://openalex.org/W2277737065","https://openalex.org/W2312004848","https://openalex.org/W2533034225","https://openalex.org/W2558279374","https://openalex.org/W2570618306","https://openalex.org/W2597045666","https://openalex.org/W2810896718","https://openalex.org/W4250877149"],"related_works":["https://openalex.org/W3131061582","https://openalex.org/W2410270796","https://openalex.org/W2810896718","https://openalex.org/W1540606473","https://openalex.org/W4410604750","https://openalex.org/W4380029636","https://openalex.org/W4394833122","https://openalex.org/W3176339725","https://openalex.org/W2883212521","https://openalex.org/W2560529694"],"abstract_inverted_index":{"Few":[0],"treatment":[1],"options":[2],"are":[3],"available":[4],"for":[5],"acute":[6],"myeloid":[7],"leukemia":[8],"(AML)":[9],"patients.":[10],"DCLL9718A":[11,48,84,145,150,182,207],"is":[12,24,36],"an":[13,50],"antibody-drug":[14],"conjugate":[15],"that":[16],"targets":[17],"C-type":[18],"lectin-like":[19],"molecule-1":[20],"(CLL-1).":[21],"This":[22,132],"receptor":[23,204],"prevalent":[25],"on":[26,39,178],"monocytes,":[27],"neutrophils,":[28],"and":[29,33,73,80,85,89,106,151,161,198,206,213,227],"AML":[30],"blast":[31],"cells,":[32,42],"unlike":[34],"CD33,":[35],"not":[37],"expressed":[38],"hematopoietic":[40,46],"stem":[41],"thus":[43],"providing":[44],"possible":[45],"recovery.":[47],"comprises":[49],"anti-CLL-1":[51],"IgG1":[52],"antibody":[53,128,147],"(MCLL0517A)":[54],"linked":[55],"to":[56,126,144],"a":[57,63,167],"pyrrolobenzodiazepine":[58],"(PBD)":[59],"dimer":[60,105,122,140],"payload,":[61],"via":[62],"cleavable":[64],"disulfide-labile":[65],"linker.":[66],"Here,":[67],"we":[68],"characterize":[69],"the":[70,77,120,127,157,179],"in":[71,74,87,98,135,156,164,186,225],"vitro":[72],"vivo":[75,136],"stability,":[76],"pharmacokinetics":[78],"(PK)":[79],"pharmacodynamics":[81],"(PD)":[82],"of":[83,119,176,181,210],"MCLL0517A":[86,152,189],"rodents":[88],"cynomolgus":[90,165,187],"monkeys.":[91],"Three":[92],"key":[93],"PK":[94,155,163,171],"analytes":[95],"were":[96],"measured":[97,202],"these":[99],"studies:":[100],"total":[101,146,183],"antibody,":[102],"antibody-conjugated":[103,138],"PBD":[104,108,121,139],"unconjugated":[107],"dimer.":[109],"In":[110],"vitro,":[111],"DCLL9718A,":[112],"was":[113,133],"stable":[114],"with":[115,137],"most":[116],"(>":[117],"80%)":[118],"payload":[123],"remaining":[124],"conjugated":[125],"over":[129],"96":[130],"hours.":[131],"recapitulated":[134],"clearance":[141],"estimates":[142],"similar":[143],"clearance.":[148],"Both":[149],"showed":[153,190,216],"linear":[154],"non-binding":[158],"rodent":[159],"species,":[160],"non-linear":[162],"monkeys,":[166],"binding":[168],"species.":[169],"The":[170],"data":[172],"indicated":[173],"minimal":[174],"impact":[175],"conjugation":[177],"disposition":[180],"antibody.":[184],"Finally,":[185],"monkey,":[188],"target":[191],"engagement":[192],"at":[193],"all":[194],"doses":[195,209],"tested":[196],"(0.5":[197],"20":[199],"mg/kg)":[200,215],"as":[201,220],"by":[203,222],"occupancy,":[205],"(at":[208],"0.05,":[211],"0.1":[212],"0.2":[214],"strong":[217],"PD":[218],"activity":[219],"evidenced":[221],"notable":[223],"reduction":[224],"monocytes":[226],"neutrophils.":[228]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2018-09-27T00:00:00"}